Gaps in guideline-recommended anticoagulation in patients with atrial fibrillation and elevated thromboembolic risk within an integrated healthcare delivery system.

ABSTRACT:

Background

Atrial Fibrillation (AF) is the leading cause of stroke, which can be reduced by 70% with appropriate oral anticoagulation (OAC) therapy. Nationally, appropriate anticoagulation rates for patients with AF with elevated thromboembolic risk are as low as 50% even across the highest stroke risk cohorts. This study aims to evaluate the variability of appropriate anticoagulation rates among patients by sex, ethnicity, and socioeconomic status within the Kaiser Permanente Mid-Atlantic States (KPMAS).

Methods

This retrospective study investigated 9513 patients in KPMAS's AF registry with CHADS₂ score ≥ 2 over a 6-month period in 2021.

Results

Appropriately anticoagulated patients had higher rates of diabetes, prior stroke, and congestive heart failure t

SUBMITTER: Malik S 

PROVIDER: S-EPMC10664365 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature